common greenlandic tbc1d4 variant confers muscle insulin resistance type diabetes
greenlandic population small historically isolated founder population comprising inhabitants experienced dramatic increase type diabetes t2d prevalence past years motivated performed association mapping t2d-related quantitative traits greenlandic individuals without known diabetes using array-based genotyping exome sequencing discovered nonsense parg684ter variant arginine replaced termination codon gene tbc1d4 allele frequency % show homozygous carriers variant markedly higher concentrations plasma glucosebeta mmol l- p x - serum insulin beta pmol l- p x - hours oral glucose load compared individuals genotypes non-carriers heterozygous carriers furthermore homozygous carriers marginally lower concentrations fasting plasma glucose beta mmol l- p x - fasting serum insulin beta pmol l- p t2d risk markedly increased odds ratio p x - heterozygous carriers moderately higher plasma glucose concentration hours oral glucose load non-carriers beta mmol l- p x - analyses skeletal muscle biopsies showed lower messenger rna protein levels long isoform tbc1d4 lower muscle protein levels glucose transporter glut4 increasing number parg684ter alleles findings concomitant severely decreased insulin-stimulated glucose uptake muscle leading postprandial hyperglycaemia impaired glucose tolerance t2d observed effect sizes several times larger previous findings large-scale genome-wide association studies traits- constitute proof value conducting genetic association studies outside traditional setting large homogeneous populations
